ISG15 expression correlates with HIV-1 viral load and with factors regulating T cell response

Immunobiology

Volumn 221, Issue 2, 2016, Pages 282-290

  Mezzaroma, Ivano ^b   Vullo, Vincenzo ^b   Selvaggi, Carla ^a   Pierangeli, Alessandra ^a   Turriziani, Ombretta ^a   Gentile, Massimo ^a   Antonelli, Guido ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

APOBEC3F; APOBEC3G; HIV 1; IDO; IFN; ISG15; TRAIL

Indexed keywords

APOLIPOPROTEIN B MESSENGER RNA EDITING ENZYME CATALYTIC POLYPEPTIDE 3F; APOLIPOPROTEIN B MESSENGER RNA EDITING ENZYME CATALYTIC POLYPEPTIDE 3G; ASPARAGINE; INDOLEAMINE 2,3 DIOXYGENASE; INTERFERON STIMULATED GENE 15 PROTEIN; INTERFERON STIMULATED GENE 56 PROTEIN; SERINE; TRANSCRIPTION FACTOR; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; UNCLASSIFIED DRUG; VIRUS DNA; VIRUS RNA; APOBEC3F PROTEIN, HUMAN; APOBEC3G PROTEIN, HUMAN; CYTIDINE DEAMINASE; CYTOKINE; CYTOSINE DEAMINASE; INDOLEAMINE 2,3-DIOXYGENASE 1, HUMAN; ISG15 PROTEIN, HUMAN; ISG56 PROTEIN, HUMAN; MESSENGER RNA; TNFSF10 PROTEIN, HUMAN; UBIQUITIN;

5' UNTRANSLATED REGION; ADULT; AMINO ACID SUBSTITUTION; APOBEC3F GENE; APOBEC3G GENE; ARTICLE; CD4 LYMPHOCYTE COUNT; COMPARATIVE STUDY; CONTROLLED STUDY; CORRELATIONAL STUDY; EXON; FEMALE; GENE; GENE EXPRESSION; GENETIC VARIATION; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; IDO GENE; ISG15 GENE; ISG56 GENE; ITALY; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PROTEIN EXPRESSION; PROTEIN FUNCTION; SINGLE NUCLEOTIDE POLYMORPHISM; T LYMPHOCYTE; TRAIL GENE; VIRAL TROPISM; VIRUS LOAD; CASE CONTROL STUDY; CD4+ T LYMPHOCYTE; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; HIV INFECTIONS; IMMUNOLOGY; SIGNAL TRANSDUCTION; VIREMIA; VIROLOGY;

ADULT; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CASE-CONTROL STUDIES; CD4 LYMPHOCYTE COUNT; CD4-POSITIVE T-LYMPHOCYTES; CYTIDINE DEAMINASE; CYTOKINES; CYTOSINE DEAMINASE; FEMALE; GENE EXPRESSION REGULATION; HIV INFECTIONS; HIV-1; HUMANS; INDOLEAMINE-PYRROLE 2,3,-DIOXYGENASE; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; RNA, MESSENGER; SIGNAL TRANSDUCTION; TNF-RELATED APOPTOSIS-INDUCING LIGAND; TRANSCRIPTION FACTORS; UBIQUITINS; VIRAL LOAD; VIRAL TROPISM; VIREMIA;

EID: 84964523464     PISSN: 01712985     EISSN: 18783279     Source Type: Journal    
DOI: 10.1016/j.imbio.2015.10.007     Document Type: Article

References (52)

1. Abdel-Mohsen, M., Raposo, R.A., Deng, X., Li, M., Liegler, T., Sinclair, E., et al. Expression profile of host restriction factors in HIV-1 elite controllers. Retrovirology, 10, 2013, 106.
2. Abel, K., Alegria-Hartman, M.J., Rothaeusler, K., Marthas, M., Miller, C.J., The relationship between simian immunodeficiency virus RNA levels and the mRNA levels of alpha/beta interferons (IFN-alpha/beta) and IFN-alpha/beta-inducible Mx in lymphoid tissues of rhesus macaques during acute and chronic infection. J. Virol. 76 (2002), 8433–8445.
3. Alidjinou, E.K., Bocket, L., Hober, D., Quantification of viral DNA during HIV-1 infection: a review of relevant clinical uses and laboratory methods. Pathol. Biol. (Paris), 2014.
4. Audigé, A., Urosevic, M., Schlaepfer, E., Walker, R., Powell, D., Hallenberger, S., et al. Anti-HIV state but not apoptosis depends on IFN signature in CD4+ T cells. J. Immunol. 177 (2006), 6227–6237.
5. Boasso, A., Herbeuval, J.P., Hardy, A.W., Anderson, S.A., Dolan, M.J., Fuchs, D., et al. HIV inhibits CD4+ T-cell proliferation by inducing indoleamine 2,3-dioxygenase in plasmacytoid dendritic cells. Blood 109 (2007), 3351–3359.
6. Boasso, A., Type I interferon at the interface of antiviral immunity and immune regulation: the curious case of HIV-1. Scientifica (Cairo), 2013.
7. Bon, I., Turriziani, O., Musumeci, G., Clò, A., Montagna, C., Morini, S., et al. HIV-1 coreceptor usage in paired plasma RNA and proviral DNA from patients with acute and chronic infection never treated with antiretroviral therapy. J. Med. Virol. 87 (2015), 315–322.
8. Borrow, P., Innate immunity in acute HIV-1 infection. Curr. Opin. HIV AIDS 6 (2011), 353–363.
9. Bosinger, S.E., Hosiawa, K.A., Cameron, M.J., Persad, D., Ran, L., Xu, L., et al. Gene expression profiling of host response in models of acute HIV infection. J. Immunol. 173 (2004), 6858–6863.
10. Cha, L., Berry, C.M., Nolan, D., Castley, A., Fernandez, S., French, M.A., Interferon-alpha, immune activation and immune dysfunction in treated HIV infection. Clin. Trans. Immunol., 3, 2014, e10.
11. Chang, J.J., Woods, M., Lindsay, R.J., Doyle, E.H., Griesbeck, M., Chan, E.S., et al. Higher expression of several interferon-stimulated genes in HIV-1-infected females after adjusting for the level of viral replication. J. Infect. Dis. 208 (2013), 830–838.
12. De Pasquale, M., Kourteva, Y., Allos, T., D'Aquila, R.T., Lower, H.I.V., provirus levels are associated with more APOBEC3G protein in blood resting memory CD4+ T lymphocytes of controllers in vivo. PLoS One, 8, 2013, e76002.
13. Ghaffari, S., Jagani, Z., Kitidis, C., Lodish, H.F., Khosravi-Far, R., Cytokines and BCR-ABL mediate suppression of TRAIL-induced apoptosis through inhibition of forkhead FOXO3a transcription factor. Proc. Natl. Acad. Sci. U. S. A. 100 (2003), 6523–6528.
14. Gorry, P.R., Ancuta, P., Coreceptors and HIV-1 pathogenesis. Curr. HIV/AIDS Rep. 8 (2011), 45–53.
15. Herbeuval, J.P., Boasso, A., Grivel, J.C., Hardy, A.W., Anderson, S.A., Dolan, M.J., et al. TNF-related apoptosis-inducing ligand (TRAIL) in HIV-1-infected patients and its in vitro production by antigen-presenting cells. Blood 105 (2005), 2458–2464.
16. Herbeuval, J.P., Nilsson, J., Boasso, A., Hardy, A.W., Kruhlak, M.J., Anderson, S.A., et al. Differential expression of IFN-alpha and TRAIL/DR5 in lymphoid tissue of progressor versus nonprogressor HIV-1-infected patients. Proc. Natl. Acad. Sci. U. S. A. 103 (2006), 7000–7005.
17. Hughes, R., Towers, G., Noursadeghi, M., Innate immune interferon responses to human immunodeficiency virus-1 infection. Rev. Med. Virol. 22 (2012), 257–266.
18. Hyrcza, M.D., Kovacs, C., Loutfy, M., Halpenny, R., Heisler, L., Yang, S., et al. Distinct transcriptional profiles in ex vivo CD4+ and CD8+ T cells are established early in human immunodeficiency virus type 1 infection and are characterized by a chronic interferon response as well as extensive transcriptional changes in CD8+ T cells. J. Virol. 81 (2007), 3477–3486.
19. Klatt, N.R., Bosinger, S.E., Peck, M., Richert-Spuhler, L.E., Heigele, A., Gile, J.P., et al. Limited HIV infection of central memory and stem cell memory CD4+ T cells is associated with lack of progression in viremic individuals. PLoS Pathog., 10, 2014, e1004345.
20. Kluge, S.F., Sauter, D., Vogl, M., Peeters, M., Li, Y., Bibollet-Ruche, F., et al. The transmembrane domain of HIV-1 Vpu is sufficient to confer anti-tetherin activity to SIVcpz and SIVgor Vpu proteins: cytoplasmic determinants of Vpu function. Retrovirology, 10, 2013, 32.
21. Larsson, M., Shankar, E.M., Che, K.F., Saeidi, A., Ellegård, R., Barathan, M., et al. Molecular signatures of T-cell inhibition in HIV-1 infection. Retrovirology, 10, 2013, 31.
22. Liszewski, M.K., Jianqing, J., O'Doherty, U., Detecting HIV-1 integration by repetitive-sampling Alu-gag PCR. Methods 47 (2009), 254–260.
23. Lu, G., Reinert, J.T., Pitha-Rowe, I., Okumura, A., Kellum, M., Knobeloch, K.P., et al. ISG15 enhances the innate antiviral response by inhibition of IRF-3 degradation. Cell. Mol. Biol. (Noisy-le-grand) 52 (2006), 29–41.
24. Malakhova, O.A., Yan, M., Malakhov, M.P., Yuan, Y., Ritchie, K.J., Kim, K.I., et al. Protein ISGylation modulates the JAK-STAT signaling pathway. Genes Dev. 17 (2003), 455–460.
25. Manini, I., Sgorbissa, A., Potu, H., Tomasella, A., Brancolini, C., The DeISGylase USP18 limits TRAIL-induced apoptosis through the regulation of TRAIL levels: cellular levels of TRAIL influences responsiveness to TRAIL-induced apoptosis. Cancer Biol. Ther. 14 (2013), 1158–1166.
26. Mir, K.D., Gasper, M.A., Sundaravaradan, V., Sodora, D.L., SIV infection in natural hosts: resolution of immune activation during the acute-to-chronic transition phase. Microbes Infect. 13 (2011), 14–24.
27. Morales, D.J., Lenschow, D.J., The antiviral activities of ISG15. J. Mol. Biol. 425 (2013), 4995–5008.
28. Nissen, S.K., Højen, J.F., Andersen, K.L., Kofod-Olsen, E., Berg, R.K., Paludan, S.R., et al. Innate DNA sensing is impaired in HIV patients and IFI16 expression correlates to chronic immune activation. Clin. Exp. Immunol. 1771 (2014), 295–309.
29. Okumura, A., Lu, G., Pitha-Rowe, I., Pitha, P.M., Innate antiviral response targets HIV-1 release by the induction of ubiquitin-like protein ISG15. Proc. Natl. Acad. Sci. U. S. A. 103 (2006), 1440–1445.
30. Okumura, F., Okumura, A.J., Uematsu, K., Hatakeyama, S., Zhang, D.E., Kamura, T., Activation of double-stranded RNA-activated protein kinase (PKR) by interferon-stimulated gene 15 (ISG15) modification down-regulates protein translation. J. Biol. Chem. 288 (2013), 2839–2847.
31. Paiardini, M., Isett, R.B., Baldwin, D.A., Else, J.G., Staprans, S.I., Silvestri, G., Global genomic analysis reveals rapid control of a robust innate response in SIV-infected sooty mangabeys. J. Clin. Invest. 119 (2009), 3556–3572.
32. Parrish, N.F., Gao, F., Li, H., Giorgi, E.E., Barbian, H.J., Parrish, E.H., et al. Phenotypic properties of transmitted founder HIV-1. Proc. Natl. Acad. Sci. U. S. A. 110 (2013), 6626–6633.
33. Pierangeli, A., Degener, A.M., Ferreri, M.L., Riva, E., Rizzo, B., Turriziani, O., et al. Interferon-induced gene expression in cervical mucosa during human papillomavirus infection. Int. J. Immunopathol. Pharmacol. 24 (2011), 217–223.
34. Pincetic, A., Kuang, Z., Seo, E.J., Leis, J., The interferon-induced gene ISG15 blocks retrovirus release from cells late in the budding process. J. Virol. 84 (2010), 4725–4736.
35. Potu, H., Sgorbissa, A., Brancolini, C., Identification of USP18 as an important regulator of the susceptibility to IFN-alpha and drug-induced apoptosis. Cancer Res. 70 (2010), 655–665.
36. Prosperi, M.C., Bracciale, L., Fabbiani, M., Di, G., iambenedetto, S., Razzolini, F., Meini, G., et al. Comparative determination of HIV-1 co-receptor tropism by enhanced sensitivity trofile, gp120 V3-loop RNA and DNA genotyping. Retrovirology, 7, 2010, 56.
37. Recht, M., Borden, E.C., Knight, E. Jr., A human 15-kDa IFN-induced protein induces the secretion of IFN-gamma. J. Immunol. 147 (1991), 2617–2623.
38. Refsland, E.W., Stenglein, M.D., Shindo, K., Albin, J.S., Brown, W.L., Harris, R.S., Quantitative profiling of the full APOBEC3 mRNA repertoire in lymphocytes and tissues: implications for HIV-1 restriction. Nucleic Acids Res. 38 (2010), 4274–4284.
39. Rotger, M., Dang, K.K., Fellay, J., Heinzen, E.L., Feng, S., Descombes, P., et al. Genome-wide mRNA expression correlates of viral control in CD4+ T-cells from HIV-1-infected individuals. PLoS Pathog., 6, 2010, e1000781.
40. Rotger, M., Dalmau, J., Rauch, A., McLaren, P., Bosinger, S.E., Martinez, R., et al. Comparative transcriptomics of extreme phenotypes of human HIV-1 infection and SIV infection in sooty mangabey and rhesus macaque. J. Clin. Invest. 121 (2011), 2391–2400.
41. Scagnolari, C., Midulla, F., Selvaggi, C., Monteleone, K., Bonci, E., Papoff, P., et al. Evaluation of viral load in infants hospitalized with bronchiolitis caused by respiratory syncytial virus. Med. Microbiol. Immunol. 201 (2012), 311–317.
42. Schaefer, T.M., Fuller, C.L., Basu, S., Fallert, B.A., Poveda, S.L., Sanghavi, S.K., et al. Increased expression of interferon-inducible genes in macaque lung tissues during simian immunodeficiency virus infection. Microbes Infect. 8 (2006), 1839–1850.
43. Sharp, P.M., Hahn, B.H., Origins of HIV and the AIDS pandemic. Cold Spring Harbor Perspect. Med., 1, 2011, a006841.
44. Sloan, R.D., Wainberg, M.A., The role of unintegrated DNA in HIV infection. Retrovirology, 8, 2011, 52.
45. Stacey, A.R., Norris, P.J., Qin, L., Haygreen, E.A., Taylor, E., Heitman, J., et al. Induction of a striking systemic cytokine cascade prior to peak viremia in acute human immunodeficiency virus type 1 infection, in contrast to more modest and delayed responses in acute hepatitis B and C virus infections. J. Virol. 83 (2009), 3719–3733.
46. Stoddart, C.A., Keir, M.E., McCune, J.M., IFN-alpha-induced upregulation of CCR5 leads to expanded HIV tropism in vivo. PLoS Pathog., 6, 2010, e1000766.
47. Trinchieri, G., Type I interferon: friend or foe. J. Exp. Med. 207 (2010), 2053–2063.
48. Van Lint, C., Bouchat, S., Marcello, A., HIV-1 transcription and latency: an update. Retrovirology, 10, 2013, 67.
49. Viard, J.P., Burgard, M., Hubert, J.B., Aaron, L., Rabian, C., Pertuiset, N., et al. Impact of 5 years of maximally successful highly active antiretroviral therapy on CD4+ T cell count and HIV-1 DNA level. AIDS 18 (2004), 45–49.
50. Yamamoto, R., Yamamoto, Y., Imai, S., Fukutomi, R., Ozawa, Y., Abe, M., et al. Effects of various phytochemicals on indoleamine 2,3-dioxygenase 1 activity: galanal is a novel, competitive inhibitor of the enzyme. PLoS One, 9, 2014, e88789.
51. Zhang, X., Bogunovic, D., Payelle-Brogard, B., Francois-Newton, V., Speer, S.D., Yuan, C., et al. Human intracellular ISG15 prevents interferon-α/β over-amplification and auto-inflammation. Nature 517 (2014), 89–93.
52. Zhao, C., Denison, C., Huibregtse, J.M., Gygi, S., Krug, R.M., Human ISG15 conjugation targets both IFN-induced and constitutively expressed proteins functioning in diverse cellular pathways. Proc. Natl. Acad. Sci. U. S. A. 102 (2005), 10200–10205.